Theralizumab
Product Specifications
CAS Number
906068-56-2
Target
Others, Immunology/Inflammation related
Related Pathways
Others, Immunology/Inflammation
Purity
0.9946
Bioactivity
Theralizumab (TGN1412) is an anti-CD28-targeting monoclonal antibody that directly stimulates T cells. Theralizumab has antitumor activity and is used for the treatment of B-cell chronic lymphocytic leukemia and rheumatoid arthritis.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![Rabbit Polyclonal RAI16 Antibody [HRP]](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
MBS6200497-01 0.1 mL
DMPK (Myotonin-protein Kinase, Myotonic Dystrophy Protein Kinase, MDPK, DM-Kinase, DMK, MT-PK, DM-kinase) (MaxLight 490)
Sign In for Pricing
View Details MBS6200497-02 5x 0.1 mL
DMPK (Myotonin-protein Kinase, Myotonic Dystrophy Protein Kinase, MDPK, DM-Kinase, DMK, MT-PK, DM-kinase) (MaxLight 490)
Sign In for Pricing
View Details 
AE59781HU-01 48 Tests
Human SH3 domain-binding glutamic acid-rich-like protein 2 (SH3BGRL2) ELISA Kit
Sign In for Pricing
View Details AE59781HU-02 96 Tests
Human SH3 domain-binding glutamic acid-rich-like protein 2 (SH3BGRL2) ELISA Kit
Sign In for Pricing
View Details